{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:07:11Z","timestamp":1778108831349,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic lymphocytic leukaemia (CLL) is the most common B-cell malignancy with a variable clinical outcome. Biomarkers of CLL progression are required for optimising prognosis and therapy. The Inhibitor of Bruton\u2019s tyrosine kinase\u2014isoform \u03b1 (<jats:italic>IBTK<\/jats:italic>\u03b1) gene encodes a substrate receptor of Cullin 3-dependent E3 ubiquitin ligase, and promotes cell survival in response to the reticulum stress. Searching for novel markers of CLL progression, we analysed the expression of<jats:italic>IBTK<\/jats:italic>\u03b1 in the peripheral blood B-cells of CLL patients, before and after first line therapy causing remission. The expression of<jats:italic>IBTK<\/jats:italic>\u03b1 was significantly increased in disease progression, and decreased in remission after chemotherapy. Consistently with a pro-survival action, RNA interference of<jats:italic>IBTK<\/jats:italic>\u03b1 increased the spontaneous and Fludarabine-induced apoptosis of MEC-1 CLL cells, and impaired the cell cycle of DeFew B-lymphoma cells by promoting the arrest in G0\/G1 phase and apoptosis. Consistently, RNA interference of<jats:italic>IBTK<\/jats:italic>\u03b1 up regulated the expression of pro-apoptotic genes, including<jats:italic>TNF<\/jats:italic>,<jats:italic>CRADD, CASP7, BNIP3 and BIRC3<\/jats:italic>. Our results indicate that<jats:italic>IBTK<\/jats:italic>\u03b1 is a novel marker of CLL progression promoting cell growth and resistance to apoptosis. In this view,<jats:italic>IBTK<\/jats:italic>\u03b1 may represent an attractive cancer drug target for counteracting the therapy-resistance of tumour cells.<\/jats:p>","DOI":"10.1038\/s41419-017-0026-3","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T18:02:44Z","timestamp":1515520964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The expression of inhibitor of bruton\u2019s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6157-7688","authenticated-orcid":false,"given":"Francesco","family":"Albano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Chiurazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selena","family":"Mimmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clementina","family":"Cimmino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Frieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Iaccino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetanina","family":"Golino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Fiume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-3856","authenticated-orcid":false,"given":"Massimo","family":"Mallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana","family":"Quinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"26_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","volume":"21","author":"N Chiorazzi","year":"2003","unstructured":"Chiorazzi, N. & Ferrarini, M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu. Rev. Immunol. 21, 841\u2013894 (2003).","journal-title":"Annu. Rev. Immunol."},{"key":"26_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/0167-5699(94)90009-4","volume":"15","author":"HW Schroeder Jr","year":"1994","unstructured":"Schroeder, H. W. Jr & Dighiero, G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol. Today 15, 288\u2013294 (1994).","journal-title":"Immunol. Today"},{"key":"26_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrc.2016.8","volume":"16","author":"G Fabbri","year":"2016","unstructured":"Fabbri, G. & Dalla-Favera, R. The molecular pathogenesis of chronic lymphocytic leukaemia. Nat. Rev. Cancer 16, 145\u2013162 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"26_CR4","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1182\/blood-2007-06-094029","volume":"110","author":"S Deaglio","year":"2007","unstructured":"Deaglio, S. et al. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood 110, 4012\u20134021 (2007).","journal-title":"Blood"},{"key":"26_CR5","doi-asserted-by":"crossref","unstructured":"Kriston, C. et al. Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL. Hematol. Oncol. 35(1):58-63 (2015).","DOI":"10.1002\/hon.2244"},{"key":"26_CR6","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1182\/blood-2011-06-275610","volume":"118","author":"F Malavasi","year":"2011","unstructured":"Malavasi, F. et al. CD38 and chronic lymphocytic leukemia: a decade later. Blood 118, 3470\u20133478 (2011).","journal-title":"Blood"},{"key":"26_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/ejh.12789","volume":"97","author":"A Rombout","year":"2016","unstructured":"Rombout, A., Verhasselt, B. & Philippe, J. Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications. Eur. J. Haematol. 97, 409\u2013415 (2016).","journal-title":"Eur. J. Haematol."},{"key":"26_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/ni1001-939","volume":"2","author":"W Liu","year":"2001","unstructured":"Liu, W. et al. Direct inhibition of Bruton\u2019s tyrosine kinase by IBtk, a Btk-binding protein. Nat. Immunol. 2, 939\u2013946 (2001).","journal-title":"Nat. Immunol."},{"key":"26_CR9","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1093\/nar\/gkn413","volume":"36","author":"C Spatuzza","year":"2008","unstructured":"Spatuzza, C. et al. Physical and functional characterisation of the genetic locus of IBtk, an inhibitor of Bruton\u2019s tyrosine kinase: evidence for three protein isoforms of IBtk. Nucleic Acids Res. 36, 4402\u20134416 (2008).","journal-title":"Nucleic Acids Res."},{"key":"26_CR10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/sj.leu.2401499","volume":"13","author":"S Stilgenbauer","year":"1999","unstructured":"Stilgenbauer, S. et al. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 13, 1331\u20131334 (1999).","journal-title":"Leukemia"},{"key":"26_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ejh.12115","volume":"91","author":"A Dalsass","year":"2013","unstructured":"Dalsass, A. et al. 6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia. Eur. J. Haematol. 91, 10\u201319 (2013).","journal-title":"Eur. J. Haematol."},{"key":"26_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/10428194.2010.542599","volume":"52","author":"DM Wang","year":"2011","unstructured":"Wang, D. M. et al. Intermediate prognosis of 6q deletion in chronic lymphocytic leukemia. Leuk. Lymphoma 52, 230\u2013237 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"26_CR13","doi-asserted-by":"crossref","unstructured":"Broseus J. et al. Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses. Oncotarget 20;7(51):83987-84002 (2016).","DOI":"10.18632\/oncotarget.9793"},{"key":"26_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.compbiolchem.2009.08.001","volume":"33","author":"G Fiume","year":"2009","unstructured":"Fiume, G. et al. Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival. Comput. Biol. Chem. 33, 434\u2013439 (2009).","journal-title":"Comput. Biol. Chem."},{"key":"26_CR15","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1182\/blood-2010-09-308080","volume":"117","author":"E Janda","year":"2011","unstructured":"Janda, E. et al. Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkgamma. Blood 117, 6520\u20136531 (2011).","journal-title":"Blood"},{"key":"26_CR16","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1074\/jbc.M114.634535","volume":"290","author":"A Pisano","year":"2015","unstructured":"Pisano, A. et al. CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation. J. Biol. Chem. 290, 13958\u201313971 (2015).","journal-title":"J. Biol. Chem."},{"key":"26_CR17","doi-asserted-by":"crossref","unstructured":"Fiume, G. et al. IBTK differently modulates gene expression and RNA splicing in HeLa and K562 cells. Int. J. Mol. Sci. 17(11), 1848 (2016).","DOI":"10.3390\/ijms17111848"},{"key":"26_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2009.05.006","volume":"137","author":"J Luo","year":"2009","unstructured":"Luo, J. et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137, 835\u2013848 (2009).","journal-title":"Cell"},{"key":"26_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/tox.21906","volume":"30","author":"TH Kim","year":"2015","unstructured":"Kim, T. H., Shin, S. W., Park, J. S. & Park, C. S. Genome wide identification and expression profile in epithelial cells exposed to TiO(2) particles. Environ. Toxicol. 30, 293\u2013300 (2015).","journal-title":"Environ. Toxicol."},{"key":"26_CR20","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1091\/mbc.E14-02-0704","volume":"25","author":"TD Baird","year":"2014","unstructured":"Baird, T. D. et al. Selective mRNA translation during eIF2 phosphorylation induces expression of IBTKalpha. Mol. Biol. Cell. 25, 1686\u20131697 (2014).","journal-title":"Mol. Biol. Cell."},{"key":"26_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/leu.2012.245","volume":"27","author":"N Cahill","year":"2013","unstructured":"Cahill, N. et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 27, 150\u2013158 (2013).","journal-title":"Leukemia"},{"key":"26_CR22","doi-asserted-by":"crossref","unstructured":"Mimmi, S. et al. Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients. Leukemia 30(12):2419-2422 (2016).","DOI":"10.1038\/leu.2016.245"},{"key":"26_CR23","first-page":"187","volume":"5","author":"F Ricci","year":"2009","unstructured":"Ricci, F., Tedeschi, A., Morra, E. & Montillo, M. Fludarabine in the treatment of chronic lymphocytic leukemia: a review. Ther. Clin. Risk Manag. 5, 187\u2013207 (2009).","journal-title":"Ther. Clin. Risk Manag."},{"key":"26_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3324\/haematol.2011.051557","volume":"97","author":"PX Fernandez-Calotti","year":"2012","unstructured":"Fernandez-Calotti, P. X., Lopez-Guerra, M., Colomer, D. & Pastor-Anglada, M. Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells. Haematologica 97, 943\u2013951 (2012).","journal-title":"Haematologica"},{"key":"26_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","volume":"23","author":"A Stacchini","year":"1999","unstructured":"Stacchini, A. et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk. Res. 23, 127\u2013136 (1999).","journal-title":"Leuk. Res."},{"key":"26_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/15257770.2011.603716","volume":"30","author":"S Henrich","year":"2011","unstructured":"Henrich, S. et al. Fludarabine nucleoside modulates nuclear \u201csurvival and death\u201d proteins in resistant chronic lymphocytic leukemia cells. Nucleosides. Nucleotides. Nucleic Acids 30, 1181\u20131189 (2011).","journal-title":"Nucleosides. Nucleotides. Nucleic Acids"},{"key":"26_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev.immunol.25.022106.141656","volume":"25","author":"HH Park","year":"2007","unstructured":"Park, H. H. et al. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 25, 561\u2013586 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"26_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/emboj.2010.326","volume":"30","author":"B Edelmann","year":"2011","unstructured":"Edelmann, B. et al. Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J. 30, 379\u2013394 (2011).","journal-title":"EMBO J."},{"key":"26_CR29","doi-asserted-by":"publisher","first-page":"a008656","DOI":"10.1101\/cshperspect.a008656","volume":"5","author":"DR McIlwain","year":"2013","unstructured":"McIlwain, D. R., Berger, T. & Mak, T. W. Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol. 5, a008656 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"26_CR30","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1080\/15548627.2015.1085136","volume":"11","author":"AH Chourasia","year":"2015","unstructured":"Chourasia, A. H. & Macleod, K. F. Tumor suppressor functions of BNIP3 and mitophagy. Autophagy 11, 1937\u20131938 (2015).","journal-title":"Autophagy"},{"key":"26_CR31","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.3892\/ol.2016.4388","volume":"11","author":"E Alhourani","year":"2016","unstructured":"Alhourani, E. et al. BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients. Oncol. Lett. 11, 3240\u20133246 (2016).","journal-title":"Oncol. Lett."},{"key":"26_CR32","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2011-12-395673","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi, D. et al. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood 119, 2854\u20132862 (2012).","journal-title":"Blood"},{"key":"26_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"JL Binet","year":"1981","unstructured":"Binet, J. L. et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48, 198\u2013206 (1981).","journal-title":"Cancer"},{"key":"26_CR34","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.4049\/jimmunol.158.9.4097","volume":"158","author":"V Giordano","year":"1997","unstructured":"Giordano, V. et al. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J. Immunol. 158, 4097\u20134103 (1997).","journal-title":"J. Immunol."},{"key":"26_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.179.3.961","volume":"179","author":"G Scala","year":"1994","unstructured":"Scala, G. et al. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med. 179, 961\u2013971 (1994).","journal-title":"J. Exp. Med."},{"key":"26_CR36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biochi.2012.12.012","volume":"95","author":"F Albano","year":"2013","unstructured":"Albano, F. et al. Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines. Biochimie 95, 934\u2013945 (2013).","journal-title":"Biochimie"},{"key":"26_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.02.013","volume":"70","author":"M Gelzo","year":"2014","unstructured":"Gelzo, M. et al. Evaluation of cytotoxic effects of 7-dehydrocholesterol on melanoma cells. Free Radic. Biol. Med. 70, 129\u2013140 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"26_CR38","doi-asserted-by":"crossref","unstructured":"Fiume, G. et al. Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice. Scientific Reports 5,\u00a013864\u00a0(2015)","DOI":"10.1038\/srep13864"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0026-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0026-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0026-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T14:12:00Z","timestamp":1693404720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0026-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1038\/s41419-017-0026-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}